Drug intelligence / Profile preview

Suo Quan Wan + Wu Lin San

Development stage: Unknown
Lead developer: Jilin Shiyu Pharmaceutical
Administration: Oral

Overview

A combination of two traditional Chinese medicine formulas used for treating urinary disorders. Suo Quan Wan consists of three herbs (Yi Zhi Ren, Wu Yao, and Shan Yao) and functions to warm the Kidneys, dispel cold, and secure Essence. Wu Lin San contains five herbs with Zhi Zi as the principal ingredient and is used to treat Damp-Cold in the Bladder. The combination is used to address various urinary symptoms including frequent urination, incontinence, and urinary dribbling.

Other names: Restrict the Fountain Pill + Powder for Five Types of Painful Urinary DribblingContracting the Spring Pill + Powder for Five Types of Painful Urinary Dribbling缩泉丸 + 五淋散

Targets

ADRB3 (β3)

Beyond the preview

Go deeper on Suo Quan Wan + Wu Lin San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suo Quan Wan + Wu Lin San.

Explore the full profile